10-K Impact 8/10 Restatement / 10-K/A

LINCOLN NATIONAL LIFE INSURANCE CO /IN/

November 17, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

The Lincoln National Life Insurance Company filed Form 10-K/A (Amendment No. 1) to restate its FY2025 annual report. The restatement corrects a mechanical error in the ceded shadow-adjustment journal entry made in Q4 2023, which overstated accumulated other comprehensive income. On November 9, 2026, the board determined previously issued financials for FY2023–FY2025 and certain 2024–2026 quarters should no longer be relied upon. Management also identified a material weakness in internal control over financial reporting, concluding disclosure controls were not effective as of December 31, 2025. Restated FY2025 figures show net income of $940M on total revenues of $15.019B.

  • Restated FY2025 net income was $940M versus $2,070M in 2024 and a $1,802M loss in 2023.
  • Total revenues rose to $15.019B in 2025 from $12.180B in 2024 (+23.3%).
  • The error overstated AOCI and stemmed from a Q4 2023 reinsurance-related journal entry setup.
  • Management concluded internal control over financial reporting was not effective as of December 31, 2025.
  • LNL is a wholly owned subsidiary of Lincoln National Corporation (LNC).
PeriodFY2025
Revenue$15.019B
Revenue YoY+23.3%
Net income$940M

Price data unavailable.

A wholly owned insurance subsidiary of Lincoln National restated three years of financials and disclosed a material control weakness, signaling governance and accounting risk at the parent.

The restatement and material weakness disclosure echo control failures seen across life insurers with complex reinsurance and shadow-adjustment accounting.

The material weakness in internal control over financial reporting raises the risk of further errors and remediation costs. The restatement also triggers amended quarterly filings for 2026 periods.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →